Evidence map›Paper›PMID 27682478›Full record

ArticleGene therapy2017

Differences in vector-genome processing and illegitimate integration of non-integrating lentiviral vectors.

A M Shaw, G L Joseph, A C Jasti, L Sastry-Dent, S Witting, K Cornetta

Abstract read
In one paragraph

Article in Gene therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Genome Editing for CNS Disorders.Frontiers in neuroscience · 2020
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

A M ShawDepartments of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
G L JosephDepartments of Microbiology, Indiana University School of Medicine, Indianapolis, IN, USA.
A C JastiDepartments of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
L Sastry-DentDepartments of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
S WittingDepartment of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital, Cincinnati, OH, USA.
K CornettaDepartments of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.

Funding

National Gene Vector Biorepository and Coordinating Center at Indiana UniversityP40HL116242 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI CORNETTA, KENNETH · 2012 to 2017
$5.5M
Indiana University Initiative for Maximizing Graduate Student DiversityR25GM079657 · NIGMS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI BRUTKIEWICZ, RANDY R · 2007 to 2010
$1.4M
NHLBI NIH HHS P40 HL116242NIGMS NIH HHS R25 GM079657
6 · The paper itself

Abstract

A variety of mutations in lentiviral vector expression systems have been shown to generate a non-integrating phenotype. We studied a novel 12 base-pair U3-long terminal repeats (LTR) integrase (IN) attachment site deletion (U3-LTR att site) mutant and found similar physical titers to the previously reported IN catalytic core mutant IN/D116N. Both mutations led to a greater than two log reduction in vector integration; with IN/D116N providing lower illegitimate integration frequency, whereas the U3-LTR att site mutant provided a higher level of transgene expression. The improved expression of the U3-LTR att site mutant could not be explained solely based on an observed modest increase in integration frequency. In evaluating processing, we noted significant differences in unintegrated vector forms, with the U3-LTR att site mutant leading to a predominance of 1-LTR circles. The mutations also differed in the manner of illegitimate integration. The U3-LTR att site mutant vector demonstrated IN-mediated integration at the intact U5-LTR att site and non-IN-mediated integration at the mutated U3-LTR att site. Finally, we combined a variety of mutations and modifications and assessed transgene expression and integration frequency to show that combining modifications can improve the potential clinical utility of non-integrating lentiviral vectors.

Indexed as

Genome, HumanGene TargetingGenetic VectorsHEK293 CellsHumansIntegrasesLentivirusMutationTerminal Repeat SequencesTransgenesVirus IntegrationIntegrases

Identifiers

PMID27682478
PMCPMC5269419

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.